We demonstrated that Myc upregulation was predominantly dependent on ALK activity, as treatments of tumor-derived JoMa1-ALK-expressing cells with TAE684 induced strong downregulation of Myc mRNA. The gene discussed is ALK; the disease is neoplasm.